Aktis Oncology, Inc. Common stock (AKTS) - Total Liabilities

Latest total liabilities as of September 2025: $411.43 Million USD

Based on the latest financial reports, Aktis Oncology, Inc. Common stock (AKTS) has total liabilities worth $411.43 Million USD as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Aktis Oncology, Inc. Common stock - Total Liabilities Trend (2013–2024)

This chart illustrates how Aktis Oncology, Inc. Common stock's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Aktis Oncology, Inc. Common stock Competitors by Total Liabilities

The table below lists competitors of Aktis Oncology, Inc. Common stock ranked by their total liabilities.

Liability Composition Analysis (2013–2024)

This chart breaks down Aktis Oncology, Inc. Common stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Aktis Oncology, Inc. Common stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Aktis Oncology, Inc. Common stock (2013–2024)

The table below shows the annual total liabilities of Aktis Oncology, Inc. Common stock from 2013 to 2024.